These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 14500395)
1. CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth. Strock CJ; Park JI; Rosen M; Dionne C; Ruggeri B; Jones-Bolin S; Denmeade SR; Ball DW; Nelkin BD Cancer Res; 2003 Sep; 63(17):5559-63. PubMed ID: 14500395 [TBL] [Abstract][Full Text] [Related]
2. RET tyrosine kinase and medullary thyroid cells are unaffected by clinical doses of STI571. Skinner MA; Safford SD; Freemerman AJ Anticancer Res; 2003; 23(5A):3601-6. PubMed ID: 14666655 [TBL] [Abstract][Full Text] [Related]
3. Cellular effects of imatinib on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated RET mutations. de Groot JW; Plaza Menacho I; Schepers H; Drenth-Diephuis LJ; Osinga J; Plukker JT; Links TP; Eggen BJ; Hofstra RM Surgery; 2006 Jun; 139(6):806-14. PubMed ID: 16782438 [TBL] [Abstract][Full Text] [Related]
4. Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma. Cuccuru G; Lanzi C; Cassinelli G; Pratesi G; Tortoreto M; Petrangolini G; Seregni E; Martinetti A; Laccabue D; Zanchi C; Zunino F J Natl Cancer Inst; 2004 Jul; 96(13):1006-14. PubMed ID: 15240784 [TBL] [Abstract][Full Text] [Related]
5. Apoptotic cell death induction and angiogenesis inhibition in large established medullary thyroid carcinoma xenografts by Ret inhibitor RPI-1. Petrangolini G; Cuccuru G; Lanzi C; Tortoreto M; Belluco S; Pratesi G; Cassinelli G; Zunino F Biochem Pharmacol; 2006 Aug; 72(4):405-14. PubMed ID: 16756963 [TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth. Ezzat S; Huang P; Dackiw A; Asa SL Clin Cancer Res; 2005 Feb; 11(3):1336-41. PubMed ID: 15709206 [TBL] [Abstract][Full Text] [Related]
7. A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. Johanson V; Ahlman H; Bernhardt P; Jansson S; Kölby L; Persson F; Stenman G; Swärd C; Wängberg B; Stridsberg M; Nilsson O Endocr Relat Cancer; 2007 Jun; 14(2):433-44. PubMed ID: 17639056 [TBL] [Abstract][Full Text] [Related]
8. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer. Bentzien F; Zuzow M; Heald N; Gibson A; Shi Y; Goon L; Yu P; Engst S; Zhang W; Huang D; Zhao L; Vysotskaia V; Chu F; Bautista R; Cancilla B; Lamb P; Joly AH; Yakes FM Thyroid; 2013 Dec; 23(12):1569-77. PubMed ID: 23705946 [TBL] [Abstract][Full Text] [Related]
10. Re: "Inhibition of medullary thyroid carcinoma (MTC) cell proliferation and RET phosphorylation by tyrosine kinase inhibitors". Plaza Menacho I; de Groot JW; Links T; Plukker J; Eggen BJ; Hofstra R Surgery; 2004 Feb; 135(2):240-1; author reply 241. PubMed ID: 14760839 [No Abstract] [Full Text] [Related]
11. Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancer. Strock CJ; Park JI; Rosen DM; Ruggeri B; Denmeade SR; Ball DW; Nelkin BD J Clin Endocrinol Metab; 2006 Jan; 91(1):79-84. PubMed ID: 16263812 [TBL] [Abstract][Full Text] [Related]
12. Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma model. Drosten M; Stiewe T; Pützer BM Hum Gene Ther; 2003 Jul; 14(10):971-82. PubMed ID: 12869215 [TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells. Arthan D; Hong SK; Park JI Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039 [TBL] [Abstract][Full Text] [Related]
14. RET signals through focal adhesion kinase in medullary thyroid cancer cells. Panta GR; Nwariaku F; Kim LT Surgery; 2004 Dec; 136(6):1212-7. PubMed ID: 15657578 [TBL] [Abstract][Full Text] [Related]
15. Targeting RET receptor tyrosine kinase activation in cancer. Phay JE; Shah MH Clin Cancer Res; 2010 Dec; 16(24):5936-41. PubMed ID: 20930041 [TBL] [Abstract][Full Text] [Related]
16. Interplay between Ret and Fap-1 regulates CD95-mediated apoptosis in medullary thyroid cancer cells. Nicolini V; Cassinelli G; Cuccuru G; Bongarzone I; Petrangolini G; Tortoreto M; Mondellini P; Casalini P; Favini E; Zaffaroni N; Zunino F; Lanzi C Biochem Pharmacol; 2011 Oct; 82(7):778-88. PubMed ID: 21741956 [TBL] [Abstract][Full Text] [Related]
17. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes. Quayle FJ; Moley JF J Surg Oncol; 2005 Mar; 89(3):122-9. PubMed ID: 15719378 [TBL] [Abstract][Full Text] [Related]
18. Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements. Gorla L; Mondellini P; Cuccuru G; Miccichè F; Cassinelli G; Cremona M; Pierotti MA; Lanzi C; Bongarzone I Mol Carcinog; 2009 Mar; 48(3):220-231. PubMed ID: 18756447 [TBL] [Abstract][Full Text] [Related]
19. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. Kameyama K; Okinaga H; Takami H Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413 [TBL] [Abstract][Full Text] [Related]
20. BAY 43-9006 inhibition of oncogenic RET mutants. Carlomagno F; Anaganti S; Guida T; Salvatore G; Troncone G; Wilhelm SM; Santoro M J Natl Cancer Inst; 2006 Mar; 98(5):326-34. PubMed ID: 16507829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]